HU9500919D0
(en )
1995-05-29
Peptide inhibitors of mitogenesis and motogenesis
HU9303218D0
(en )
1994-03-28
Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
PL314838A1
(en )
1996-09-30
Inhibitors of bp-iv-serine protease
IL110525A0
(en )
1994-11-11
Identification and use of protease inhibitors
PL310897A1
(en )
1996-01-08
Analogues of yy peptide and their application
GB2275380B
(en )
1997-02-26
VCR and method of displaying time thereof
PL327569A1
(en )
1998-12-21
Promedications of thrombosin inhibitors
PL322549A1
(en )
1998-02-02
Inhibitors of proteinous farnesiltransferase
PL308553A1
(en )
1995-08-21
Inhibitors of farnesil-protein transferase
GB9227026D0
(en )
1993-02-17
Dual inhibitors of no synthase and cycloosygenase
IL103772A0
(en )
1993-04-04
Bloodbag and method of making same
HU9402361D0
(en )
1994-10-28
New makrolides and use of them
PL298080A1
(en )
1993-10-18
Novel drivatives of 2-ketoqvinoline and method of obtaining sames
EP0702080A3
(en )
1996-06-12
Azeotropes of octamethyltri-siloxane and n-propoxypropanol
PL311300A1
(en )
1996-02-05
4-arylo-4-hydroxy-tetrahydropyranes and 3-arylo-3-hydroxy-tetrahydrofuranes as inhibitors of 5-lipoxygenase
NZ328895A
(en )
1999-03-29
Peptide antagonists containing phosphotyrosine or phosphophenylalanine derivatives of cellular mitogenesis and motogenesis
HU9600227D0
(en )
1996-03-28
Use of amides of phenyl-cyclohexyl-carboxylic acids
PL305160A1
(en )
1995-04-03
Method of obtaining a modified politetrafluoroethylene and its application
EP0713496A4
(en )
1999-03-24
Fibrin-targeted inhibitors of thrombin
PL301204A1
(en )
1994-06-13
Method of obtaining avermectines and invermectines
EP0854715A4
(en )
2001-12-19
Methods of inhibiting plasminogen activator inhibitor 1
ZA944680B
(en )
1995-02-15
Peptide inhibitors of mitogenesis and motogenesis
GB9407673D0
(en )
1994-06-08
Peptide inhibitors of mitogenesis and motogenius
GB2275314B
(en )
1996-04-10
Support member and method of use
HU9402312D0
(en )
1994-10-28
Identification and use of protease inhibitors